GRADED ANSWERS
1. How do you treat tinea capi- Antifungal
tis?
2. What specific drug is Caspofungin
used to treat
aspergillosis?
ivermectin and moxidectin
3. Which anthelmintic
drugs carry the risk for
hypoten- sion with
patients on anti-
hypertensives?
Mebendazole and Abendazole
4. Which anthelmintic
drugs can cause
bone marrow
suppression and liver
im- pairment? Pyrantel
5. Which anthelmintic
drug is generally safe
to give without
obtaining baseline Praziquantel and Moxidectin
data?
6. Which anthelmintic lactic acidosis, severe hepatomegaly with steatosis, severe
drug is safe for use in pan-
pregnancy?
7. HIV Medication: What
are
the risks associated with Di- creatitis, hepatotoxicity, non-cirrhotic portal hypertension,
im-
danosine (NRTI)?
1/
75
,CHAMBERLAIN NR 566 EXAM QUESTIONS & A+
GRADED ANSWERS
mune reconstitution syndrome, Redistribution of adipose tissu
peripheral neuropathy, retinal disorders, and/or optic
8. HIV Medication: What neuritis, headache, nausea, vomiting, and rash.
are the risks
associated with Dangerous drug interactions (danger with ritonavir),
hepatotoxi- city, pancreatitis, severe hypersensitivity
reactions, PR interval pro- longation, hyperlipidemia,
diabetes (exacerbation and new on-
2/
75
,CHAMBERLAIN NR 566 EXAM QUESTIONS & A+
GRADED ANSWERS
Saquinavir (aka set), immune reconstitution, syndrome, redistribution of
Invirase) a Protease adipose tissue, renewed bleeding in patients with
Inhibitor? hemophilia, exacerba- tion of comorbid hepatic disease,
hyperlipidemia, nausea, vomit- ing, abdominal pain,
diarrhea, and fatigue
9. P-R Interval impacts the use Protease Inhibitors can decrease the speed of cardiac
conduc-
of which HIV drugs? patients?
10. How do you measure
success with
antiretroviral therapy
for HIV?
11. What does an
increase in CD4 T
cells indicate?
12. When do we use
foscarnet in HIV+
3/
75
, CHAMBERLAIN NR 566 EXAM QUESTIONS & A+
GRADED ANSWERS
. viral load decreases, CD4 T-cell counts may rise, indicating som
restoration of immune function. Foscarnet
most common effect is a prolongation of
has two approved indications:
the PR interval. May lead to blocking
CMV (cytomegalovirus) retinitis in patients with AIDS
of the bundle branches (CMV retinitis resistant to ganciclovir may respond to foscarnet)
ockers can
worsen
this effect
A
decrease
in plasma
HIV RNA.
h ART, plasma HIV RNA should decline to
10% of baseline within 2 to 8 weeks.
r 16 to 20 weeks of treatment, plasma
HIV RNA should reach its
minimum.
lly, the minimum will be undetectable
with sensitive assays. CD4 T-Cell
Counts:
4/
75